Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Influenza Virus Research Studies, SARS-CoV-2 and COVID-19 Research, Viral Infections and Vectors, and Respiratory viral infections research.
A global atlas and drivers of antimicrobial resistance in Salmonella during 1900-2023
Enabling the immune escaped etesevimab fully-armed against SARS-CoV-2 Omicron subvariants including KP.2
CircRNA vaccine encoding a chimeric immunogen of B6 and M1 demonstrates robust immune responses against MPXV
A SARS‐CoV and SARS‐CoV‐2 RBD Heterodimer Vaccine Candidate
Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach
π-HuB: the proteomic navigator of the human body
Spatiotemporal genotype replacement of H5N8 avian influenza viruses contributed to H5N1 emergence in 2021/2022 panzootic
Long-term effects of Omicron BA.2 breakthrough infection on immunity-metabolism balance: a 6-month prospective study
A human monoclonal antibody targeting the monomeric N6 neuraminidase confers protection against avian H5N6 influenza virus infection
Fulminant myocarditis induced by SARS-CoV-2 infection without severe lung involvement: insights into COVID-19 pathogenesis
Genetic characteristics of H1N1 influenza virus outbreak in China in early 2023
A chimeric mRNA vaccine of S-RBD with HA conferring broad protection against influenza and COVID-19 variants
Structural basis for the immune recognition and selectivity of the immune receptor PVRIG for ligand Nectin-2
Multi-omic characteristics of longitudinal immune profiling after breakthrough infections caused by Omicron BA.5 sublineages
The mechanism of STING autoinhibition and activation
Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2
Near-atomic architecture of Singapore grouper iridovirus and implications for giant virus assembly
Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD
Interactions among acute respiratory viruses in Beijing, Chongqing, Guangzhou, and Shanghai, China, 2009–2019
Moving cholera vaccines ahead of the epidemic curve
Antibody response assessment of immediate breakthrough infections after zero-COVID policy adjustment in China
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates
Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines
An engineered bispecific human monoclonal antibody against SARS-CoV-2
Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2s
From concept to action: a united, holistic and One Health approach to respond to the climate change crisis
High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region
Cross-species recognition and molecular basis of SARS-CoV-2 and SARS-CoV binding to ACE2s of marine animals
Target-Based Virtual Screening and LC/MS-Guided Isolation Procedure for Identifying Phloroglucinol-Terpenoid Inhibitors of SARS-CoV-2